Alvotech announces participation at bofa securities healthcare conference 2024

Reykjavik, iceland, may 02, 2024 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of management would be participating in the upcoming bofa securities healthcare conference 2024, which will be held on may 14-15, 2024 in las vegas, nv.

ALVO Ratings Summary

ALVO Quant Ranking